On August 21, 2020, the Pharmacy and Therapeutics (P&T) Committee approved Clinical Criteria applicable to the medical drug benefit for Empire BlueCross BlueShield. These policies were developed, revised or reviewed to support clinical coding edits.


The Clinical Criteria is publicly available on the provider websites, and the effective dates will be reflected in the [Clinical Criteria Web Posting August 2020]. Visit Clinical Criteria to search for specific policies.


If you have questions or would like additional information, use this email.


EBSCRNU-0142-20 November 2020


Featured In:
January 2021 Empire Provider News